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Longitudinal Study on the Association Between Cardiorespiratory 
Fitness, Anthropometric Parameters and Blood Lipids
Evelien Mertens, Peter Clarys, Johan Lefevre, Ruben Charlier, Sara Knaeps, and Benedicte Deforche
Background: Longitudinal evidence concerning the association between cardiorespiratory fitness (CRF) and blood lipids and between anthro-
pometric parameters (ANTP) and blood lipids is limited. This study aimed to investigate the association between changes in CRF and ANTP 
and changes in blood lipids. Methods: In 2002–2004 and 2012–2014, 652 participants were tested. CRF was measured as VO2peak using a 
maximal ergometer test. Waist circumference (WC) and Body Mass Index (BMI) were used as ANTP. Blood samples were analyzed for total 
cholesterol (TC), HDL cholesterol, LDL cholesterol and triglycerides. A linear regression analysis was performed to investigate associations 
between changes in CRF and ANTP and changes in blood lipids. Results: After adjustment a decrease in CRF was associated with an increase 
in triglycerides and a decrease in HDL cholesterol in men. An increase in WC was associated with an increase in TC, LDL cholesterol and 
ratio total/HDL cholesterol and a decrease in HDL cholesterol, while an increase in BMI was associated with an increase in ratio total/HDL 
cholesterol and a decrease in HDL cholesterol. Conclusions: WC and BMI were more longitudinally associated with blood lipids compared 
with CRF. Improving ANTP can enhance the blood lipid profile, while CRF had only limited influence.
Keywords: blood cholesterol, VO2peak, body mass index, waist circumference
Although cardiovascular heart disease (CHD) is a main cause 
of death,1 the contribution of cardiorespiratory fitness (CRF) and 
anthropometric parameters (ANTP) to CHD indicators such as 
blood lipids is still controversial.2 Very few longitudinal studies 
have investigated the role of objectively measured CRF and ANTP 
in combination with circulating levels of blood lipids. Lee et al2 
found that an increase in CRF over a 6-year follow-up period was 
associated with an increase in HDL cholesterol and a decrease in 
TC and triglycerides. Furthermore, the CARDIA study found that 
improving CRF was not associated with decreasing LDL choles-
terol over a 15-year follow-up period.3 An increase in Body Mass 
Index (BMI) over a 6-year follow-up period was associated with an 
increase in TC and triglycerides and a decrease in HDL cholesterol.2 
Kaess et al4 demonstrated that an increase in BMI and waist circum-
ference (WC) were associated with a drop in HDL cholesterol and 
an increase in triglycerides over a 2-year follow-up period. While 
previous studies have provided important information, a limitation 
of these studies is that analyses were mostly corrected for but not 
stratified by gender. CRF, ANTP and blood lipids differ between men 
and women,5 while associations between those parameters may also 
be gender-specific. As a consequence, analyses stratified by gender 
may deliver more refined results taking into account these complex 
interrelationships. Findings of the few existing longitudinal studies 
are not all in the same line, possibly because of different measures 
or parameters of CRF and ANTP, diverse follow-up periods and 
different levels of correction for confounding factors. Parameters 
such as age,6 smoking,7 physical activity level (PAL),8,9 and sed-
entary behavior10 can have an influence on the blood lipid profile.
Regarding ANTP it is still not clear to what extent an increase 
in central adiposity or total adiposity is associated with a deteriorat-
ing blood lipid profile. Cross-sectional studies have shown that the 
distribution of fat is recognized as important, with central adiposity 
conferring higher disease risk.11,12
The longitudinal association between CRF and ANTP and 
the blood lipid profile needs further examination. The main aim of 
the current study was to investigate the longitudinal associations 
between CRF and blood lipids and between ANTP and blood lipids 
over a 10-year follow-up period, stratified by gender. In addition, 
we wanted to investigate these associations as a function of dif-
ferent ANTP: WC and BMI respectively. As central adiposity was 
found to confer higher disease risk in previous research,11,12 it was 
hypothesized that there would be a stronger association between 
changes in the central adiposity component (WC) and blood lipids 
compared with changes in total adiposity (BMI).
Methods
Subjects
Data were gathered by the Flemish Policy Research Centre Sport, 
Physical Activity and Health.13 This Research Centre aimed to 
investigate health behaviors, physical fitness and mental health 
among an adult population. For this purpose, the National Institute 
of Statistics selected 46 Flemish municipalities by clustered random 
sampling. Within the municipalities, a random sample of men and 
women between 18 and 75 years old was selected in 2002. Although 
small differences were observed, the sample can be considered as 
representative for geographic distribution, age, gender and educa-
tional level. The first test moment took place during 2002–2004, 
the second test moment during 2012–2014. As much as possible 
the same tests and measures performed at the first assessment 
(2002–2004) were repeated at the second assessment (2012–2014), 
although not every participant performed the test twice because of 
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technical or organizational problems or because of their risk profile. 
Of the original 1569 participants in 2002–2004, 420 men and 232 
women returned for participation in 2012–2014. All participants 
signed an informed consent. The study was approved by the ethical 
and medical committee of the KU Leuven.
Tests and Measures
Blood Samples. Participants were instructed to fast from 11:00 PM 
the evening before their visit. A fasting blood sample was taken. TC, 
HDL cholesterol, LDL cholesterol and triglyceride were determined. 
Triglyceride was analyzed using the lipase/glycerol kinase/glycerol 
phosphate oxidase enzymatic method. HDL cholesterol was analyzed 
using the homogeneous polyanion/cholesterol esterase/oxidase 
enzymatic method. Triglyceride and HDL cholesterol were measured 
on an Olympus AU5400 analyzer (Olympus Diagnostica, Hamburg, 
Germany). LDL cholesterol was calculated using the following for-
mula: LDL cholesterol = (TC – HDL cholesterol – Triglycerides) ÷ 5.14
Cardiorespiratory Fitness. CRF was measured using a maximal 
exercise test on an electrically braked cycle ergometer (Lode, Gron-
ingen, The Netherlands) applying a standardized exercise protocol. 
The test started with a workload of 20 Watt, which increased with 20 
Watt per minute. Participants were asked to cycle at about 70 rpm. 
The test leader encouraged them to reach their level of exhaustion. A 
Cortex Metalyser 3B Analyzer (Cortex Biophysic GmbH, Leipzig, 
Germany) was used to measure oxygen consumption with breath-
by-breath respiratory gas exchange analysis. This method generates 
highly reliable results.15 CRF was assessed as peak oxygen uptake 
normalized for body weight (VO2peak in ml/kg/min). For this test 
a medical screening was required, with participants being excluded 
using the following criteria: hypertension, aortic stenosis, good clini-
cal judgment, exclusion after electrocardiogram, joint degradation 
in ankle or knee, and exclusion based on family history.16–18
Anthropometric Parameters. Anthropometry was performed 
by trained staff using standardized techniques and equipment.19 
Participants were measured barefoot and in minimal clothing. WC 
and BMI were used as ANTP. WC was measured using a metal tape 
(Rosscraft, Surrey, BC, Canada) at the narrowest level between 
lowest ribs and iliac crests to the nearest 0.1 cm. Body weight was 
recorded to the nearest 0.1 kg with a digital weight scale (Seca 
841, Seca GmbH, Hamburg, Germany) and body height with a 
stadiometer (Holtain, Crymych, UK) to the nearest 0.1 cm. BMI 
was calculated using the following formula: BMI = body weight 
(kg) ÷ [height (m)]2.
Smoking Behavior. Smoking behavior was assessed using 
the WHO Monica Smoking Questionnaire.20 According to their 
responses, participants were classified into actual smokers or 
nonsmokers.
Energy Intake. Participants completed a 3-day diet record, in 
which they recorded all foods and drinks during 2 weekdays and 
1 weekend day.21 They were asked to weigh the amount of foods 
and drinks consumed if possible. Otherwise they were inquired 
to estimate the amount of the foods and drinks by using standard 
household measures (eg, glass, spoon, etc). The diet records were 
analyzed using Becel Nutrition software (Unilever Co.; Rotterdam, 
The Netherlands). Total energy intake (in kcal/day) was computed.
Screen Time. Screen time was estimated using the Flemish Physi-
cal Activity Questionnaire (FPACQ)22 and was used as a sedentary 
behavior parameter. Participants were asked to report time spent 
watching video/television or playing computer games during an 
average week day and weekend day. Screen time was calculated 
by multiplying the average week day scores by 5 and the weekend 
scores by 2, then summing both scores and dividing by 7 to obtain 
average hours of screen time per day.
Physical Activity Assessment. PAL was estimated using the 
FPACQ. The FPACQ was found to be a valid and reliable question-
naire for different components of physical activity (PA) during a 
normal week in adults.22 PAL is an indicator of the general activity 
level. The PAL expresses the PA of a person as a number and is 
calculated by dividing the total energy expenditure per week by 168 
(the number of hours per week). Total energy expenditure per week 
is calculated by summing the energy spent on working, household 
activities, leisure time activities, sleeping and eating, based on 
intensity and duration of activity.
Statistical Analysis
SPSS 21.0 (SPSS Inc. Chicago, IL) statistics software was used 
for data analysis. Normality of data were checked visually and 
with Kolmogorov-Smirnov test. Data were mostly normally dis-
tributed. Nonnormally distributed data were tested with parametric 
and nonparametric tests, but this had no influence on the nature of 
the relationships. For clarity and simplicity only the results of the 
parametric tests were presented. A drop-out analysis was performed 
by comparing baseline results between the follow-up group and the 
group that only participated in 2002–2004 using an independent 
samples t-test. A paired samples t-test was used for characterization 
of the participants and to examine if there are any differences in 
parameters between the 2 test moments. Differences in percentage 
actual smokers between the 2 test moments were investigated using 
the chi-square test. Changes in VO2peak, WC, BMI, smoking, total 
energy intake, screen time and PAL between the test periods were 
calculated using residual change scores. Residual change scores were 
created by regressing the follow-up measures onto their respective 
baseline measures. The residualized change scores can be interpreted 
as the amount of change between the first and second test moment, 
independent of baseline levels and are preferable to simple change 
scores because they eliminate auto-correlated error and regression 
to the mean effects.23 Associations between changes in ANTP, CRF 
and changes in blood lipids were tested in an unadjusted model 
using multivariate linear regression with blood lipids as continuous 
dependent variable. In an adjusted model the analyses were adjusted 
for possible confounders, such as age and changes in respectively 
smoking, energy intake, screen time and PAL. After checking for 
multicollinearity, changes in WC were used as confounder in the 
longitudinal association between CRF and blood lipids, and changes 
in CRF were used as confounder in the longitudinal association 
between ANTP and blood lipids. The analyses were stratified by 
gender. A 2-sided 0.05 level of significance was defined.
Results
In a drop-out analysis ANTP, PAL, screen time, CRF and blood 
lipids were used to assess representativeness of the present sample 
compared with those who dropped-out (Table 1). In women, the 
present sample scored significantly better on BMI, WC, PAL, 
VO2peak, HDL cholesterol, and ratio total/HDL cholesterol com-
pared with women who dropped-out. In men, the present sample 
scored significantly better on ratio total/HDL cholesterol and tri-
glycerides compared with men who dropped-out.
In Table 2 characteristics of participants are presented, as well 
as test results of the first (2002–2004) and second (2012–2014) 
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assessment. The mean (SD) age at the first assessment was 46.7 
(10.3) years in men and 44.6 (8.9) years in women. At the second 
assessment the mean (SD) was 57.3 (10.3) years in men and 55.2 
(8.9) years in women. In men, BMI, WC, screen time, and ratio total/
HDL cholesterol increased, while PAL, energy intake, VO2peak and 
HDL cholesterol decreased over the 2 assessments. In women, BMI, 
WC, screen time, TC, LDL cholesterol, and ratio total/HDL choles-
terol increased, while VO2peak decreased over the 2 assessments.
The multivariate linear regression analysis with residual change 
score in blood lipids as dependent variable and residual change 
score in CRF as independent variable is presented in Table 3. The 
unadjusted model (model 1) illustrates that a mean decrease in 
VO2peak was associated with an increase in triglycerides in men 
and women, and with an increase in ratio total/HDL cholesterol 
and a decrease in HDL cholesterol in men. This means that for 
every 1-unit decrease in VO2peak, triglycerides will increase with 
Table 1 Drop-out Analysis: Comparison of Variables Between Drop-outs and Follow-ups by Baseline Measure  
in Adults Aged 18–75 Years,* Policy Research Centre Sport Leuven, 2002–2004
Men Women
Drop-out (N = 503) Follow-up (N = 420) Drop-out (N = 414) Follow-up (N = 232)
N Mean (SD) N Mean (SD) P N Mean (SD) N Mean (SD) P
Body mass index (kg/m2) 501 25.7 (3.4) 420 25.4 (2.8) 0.148 411 24.6 (4.2) 232 23.5 (3.2) <0.001
Waist circumference (cm) 500 89.5 (10.4) 420 89.2 (8.8) 0.595 411 77.9 (10.0) 232 75.7 (7.6) 0.001
Physical activity level 484 1.8 (0.3) 399 1.8 (0.2) 0.247 406 1.7 (0.2) 223 1.7 (0.2) 0.008
Screen time (hours/day) 484 2.1 (1.3) 399 2.0 (1.1) 0.120 406 1.8 (1.2) 223 1.8 (1.1) 0.927
VO2peak relative (ml/kg/min) 434 36.9 (9.0) 389 37.5 (8.1) 0.331 380 27.2 (6.3) 218 29.3 (6.1) <0.001
Total cholesterol (mg/dl) 495 209.1 (41.4) 418 206.0 (37.5) 0.234 412 203.3 (36.4) 231 205.2 (38.8) 0.539
HDL cholesterol (mg/dl) 495 54.4 (12.5) 418 55.5 (11.7) 0.157 412 65.7 (14.8) 231 70.0 (15.4) <0.001
LDL cholesterol (mg/dl) 495 130.3 (36.5) 418 128.0 (33.8) 0.329 412 118.5 (32.0) 231 116.1 (35.0) 0.377
Ratio total/HDL cholesterol 495 4.0 (1.1) 418 3.9 (1.0) 0.027 412 3.2 (0.8) 231 3.1 (0.9) 0.016
Triglycerides (mg/dl) 495 122.4 (84.1) 418 111.8 (66.4) 0.033 412 93.9 (43.1) 231 93.3 (42.1) 0.877
Note. Differences in variables between the drop-outs and the follow-ups were tested with an independent samples t-test. There were missing values in VO2peak relative 
due to risk profile, while missing values in other variables were due to technical or organizational problems.
* Drop-out men = 503, follow-up men = 420, drop-out women = 414, follow-up women = 232.
Table 2 Characteristics of the Participants: Comparison of Variables Between the 2 Test Moments  
in Adults Aged 18–75 Years at Baseline and 28–85 Years at Follow-up (Men = 420, Women = 232),  
Policy Research Centre Sport Leuven, 2002–2004 and 2012–2014
Men (N = 420) Women (N = 232)
2002–2004 2012–2014 2002–2004 2012–2014
N Mean (SD) Mean (SD) Change P N Mean (SD) Mean (SD) Change P
Age (years) 420 46.7 (10.3) 57.3 (10.3) –10.6 <0.001 232 44.6 (8.9) 55.2 (8.9) –10.6 <0.001
Body Mass Index (kg/m2) 420 25.4 (2.8) 25.8 (3.1) –0.4 <0.001 232 23.5 (3.2) 24.3 (3.6) –0.8 <0.001
Waist circumference (cm) 420 89.2 (8.8) 90.2 (9.0) –1.0 <0.001 232 75.7 (7.6) 78.0 (8.7) –2.3 <0.001
Physical Activity Level 391 1.8 (0.2) 1.8 (0.3) 0.0 0.007 216 1.7 (0.2) 1.7 (0.2) 0.0 0.418
Screen time (hours/day) 391 2.0 (1.1) 2.3 (1.2) –0.3 <0.001 216 1.8 (1.1) 2.1 (1.2) –0.3 <0.001
Energy intake (kcal/day) 373 2590.3 (672.7) 2421.4 (622.1) 168.9 <0.001 197 2037.5 (512.2) 1961.9 (541.8) 75.6 0.060
VO2peak relative (ml/kg/min) 314 38.4 (7.9) 37.2 (8.7) 1.2 0.001 184 29.6 (6.2) 28.0 (6.1) 1.6 <0.001
Total cholesterol (mg/dl) 410 206.4 (37.6) 206.0 (38.3) 0.4 0.806 227 204.7 (38.5) 222.3 (36.1) –17.6 <0.001
HDL cholesterol (mg/dl) 410 55.5 (11.7) 53.7 (11.6) 1.8 <0.001 227 70.3 (15.3) 68.9 (15.1) 1.4 0.123
LDL cholesterol (mg/dl) 410 128.1 (33.8) 130.6 (33.8) –2.5 0.114 227 115.8 (35.1) 134.7 (31.5) –18.9 <0.001
Ratio total/HDL cholesterol 410 3.9 (1.0) 4.0 (1.1) –0.1 0.003 227 3.0 (0.9) 3.4 (0.9) –0.4 <0.001
Triglycerides (mg/dl) 410 111.1 (66.9) 109.4 (72.8) 1.7 0.447 227 92.1 (39.5) 95.2 (52.4) –3.1 0.332
N % % P chi2 N % % P chi2
Actual smokers (%) 410 14.3 9.1 5.2 <0.001 227 13.4 7.9 5.5 <0.001
Note. Differences in variables between the 2 test periods were tested with a paired samples t-test. Differences in actual smokers between the 2 test periods were calculated with 
a chi-square test. There were missing values in VO2peak relative due to risk profile, while missing values in other variables were due to technical or organizational problems.
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respectively 0.215 mg/dl and 0.153 mg/dl in men and women. After 
adjustment for potential confounders (model 2) a mean decrease in 
VO2peak was associated with an increase in triglycerides in men 
and women and with a decrease in HDL cholesterol in men. This 
means that for every 1-unit decrease in VO2peak, triglycerides will 
increase with 0.217 mg/dl in men and with 0.184 mg/dl women 
and HDL cholesterol will decrease with 0.332 mg/dl in men after 
adjustment for potential confounders (model 2).
The multivariate linear regression analysis with residual change 
score in blood lipids as dependent variable and residual change score 
in ANTP as independent variable is presented in Table 4. In the 
unadjusted model (model 1), a mean increase in WC was associated 
with an increase in TC, LDL cholesterol, ratio total/HDL cholesterol 
and with a decrease in HDL cholesterol in men and women and with 
an increase in triglycerides in men. A mean increase in BMI was 
associated with an increase in TC, LDL cholesterol, ratio total/HDL 
cholesterol, triglycerides, and with a decrease in HDL cholesterol in 
men and women. After adjustment for potential confounders (model 
2) a mean increase in WC was associated with an increase in TC, 
LDL cholesterol, ratio total/HDL cholesterol, and with a decrease 
in HDL cholesterol in men and women and with an increase in 
triglycerides in men. A mean increase in BMI was associated with 
an increase in ratio total/HDL cholesterol and with a decrease in 
HDL cholesterol in men and women and with an increase in TC and 
LDL cholesterol in women. In men, WC showed more and stronger 
longitudinal associations with blood lipids compared with BMI.
Discussion
This study investigated the associations between changes in CRF 
and ANTP and changes in blood lipids over a 10-year follow-up 
period. To evaluate the effect of potential confounders, unadjusted 
and adjusted analyses were performed, stratified by gender.
ANTP was more strongly associated with blood lipids com-
pared with CRF, both in the adjusted and the unadjusted analyses 
and both in men and women. CRF was only poorly longitudinally 
associated with blood lipids, with slightly more associations found in 
men compared with women, both in the unadjusted and the adjusted 
analysis. The paucity of longitudinal associations between CRF and 
blood lipids and the low explained variance of the predictor variables 
can be attributed to different factors. CRF is a combination of genetic 
aspects, PA and functional health of several organ systems.24 There 
is a wide variability in the response to CRF, which is interindividual 
and under environmental control.25 In addition, other factors such 
as diet, inflammation, oxidative stress, immune dysfunction and 
genetic parameters may be underlying causes of hyperlipidemia.26 
Another possible explanation for the few longitudinal associations 
may be the health status of the participants. The drop-out analysis 
showed that especially in women volunteers who participated at 
follow-up had a significantly higher baseline fitness level compared 
with those who dropped-out. Possibly the change scores were too 
small to detect longitudinal associations with blood lipids.
Comparing our results with those of previous longitudinal 
research is difficult, because in other studies the analyses were 
mostly corrected for and not stratified by gender and mostly a 
smaller age range was included. The results of the adjusted longitu-
dinal analysis between CRF and blood lipids are in accordance with 
those from the CARDIA study, where CRF was not longitudinally 
associated with LDL cholesterol after adjustment for potential 
confounders.3 The favorable longitudinal association between CRF 
and TC, triglycerides, and HDL cholesterol found in the study of 
Lee et al2 was only partly confirmed in the current study, possibly 
because of the longer duration of the follow-up period in combina-
tion with the level of controlling for confounders. In the study of 
Lee et al2 the analyses were adjusted for age, gender, changes in 
percentage body fat and dummy variables for changes in physical 
activity, smoking status and alcohol intake, while in the current 
study the analyses were also adjusted for changes in energy intake 
and screen time but not for alcohol intake.
In contrast with CRF, changes in WC (both in men and women) 
and BMI (mainly in women) were more strongly associated with 
changes in blood lipids after adjustment for potential confounders. 
Since BMI does not take into account the distribution between 
fat mass and fat free mass, its value in relation to health is often 
questioned.27 However, in this longitudinal design with an on aver-
age middle-aged population an increase in BMI is most probably 
attributed to an increase in fat mass. The latter may explain its value 
in the longitudinal association with blood lipids. An increase in the 
ANTP, both in men and women and both in the nonadjusted and the 
adjusted analysis, was significantly associated with an increase in 
ratio total/HDL cholesterol. Ratio total/HDL cholesterol is consid-
ered as a crucial cardiovascular health parameter28 but was despite 
its importance not included in previous longitudinal research. For 
health promotion this finding can be meaningful, since ANTP can 
be improved with sustained low- to moderate-intensity exercise 
and daily PA, while improvement of CRF is also possible with 
moderate-intensity exercise but requires more high-intensity training 
to achieve greater results.29 High-intensity training programs also 
show higher drop-out rates and injury incidence.29 Weight loss and 
fat oxidation can also be accomplished by regular participation in 
low- to moderate-intensity exercise which generally shows long-
term adherence.30 In general findings from the current study are in 
agreement with previous longitudinal research,2,4 where a decrease 
in ANTP is associated with a deteriorating blood lipid profile.
We also compared associations with blood lipids between 
the central adiposity component (assessed by WC) and the total 
adiposity component (assessed by BMI). We could only partly 
confirm the proposed hypothesis that changes in the central adipos-
ity component would be more associated with changes in blood 
lipids compared with changes in total adiposity. The results of the 
current study indicate that in men an increase in WC was strongly 
associated with a deteriorated blood lipid profile after adjustment 
for potential confounders. In women both changes in WC and BMI 
were equally associated with changes in blood lipids after adjust-
ment for potential confounders.
There are some limitations to this study. Since on average 
healthier people tend to participate in health-related research 
projects,31 the external validity may be limited. Selective drop-out 
toward the second measurement has implications for the internal 
and external validity. However, drop-out is a typical phenomenon 
in longitudinal studies.32 Because of the selective sample, find-
ings of the current study may not be applicable to less healthy 
or unhealthy populations. Another limitation is that we could not 
adjust for environmental factors, cholesterol medication and meno-
pausal status in women, because this information was not available. 
Also the fact that BMI is used as an indicator for total adiposity 
is a limitation, as it does not distinguish lean mass and fat mass. 
However, BMI has proven to be a useful parameter in the associa-
tion with health,33,34 although the use of more recently developed 
devices such as Bodpod as an estimate of body fat percentage 
would provide additional information. The strengths of the current 
study are the longitudinal study design with a follow-up period of 
10 years in adults with a wide age range (between 18 and 75 years 
old at baseline), the inclusion of strong objective measures at both 
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measure points and the integration of confounders. Also a complete 
blood lipid profile was determined, with 5 parameters (including 
ratio total/HDL cholesterol) instead of a less complete blood lipid 
profile commonly used in previous studies.
Conclusions
ANTP showed more and stronger longitudinal associations with 
blood lipids after adjustment for potential confounders compared 
with CRF. An increase in WC and in women also BMI was more 
strongly associated with a deteriorated blood lipid profile. Ratio total/
HDL cholesterol, a strong mortality indicator, has been found to be 
the most influenced cardiovascular health parameter by the ANTP.
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